The companies have teamed up to develop Takeda’s proprietary induced pluripotent stem cell (iPSC) derived CAR-T cell ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

The most comprehensive map of the developing human thymus sheds light on how immune responses are built and maintained at early life, with implications for understanding and treating immunodeficiency, ...

T therapy targeting p95HER2 shows complete and durable tumor responses in HER2+ breast cancer preclinical models. Combining ...

The Trivedi Group at EMBL Barcelona studies how cells give rise to our body plan and has now published a study in the journal Development that may enhance our understanding of early mammalian ...

Spokeo analyzed cellphone ownership rates among children and gathered tips from child development experts for determining ...

You can’t keep a good idea down, or so they say. And hydrogen is a very good idea. Even Chancellor Rachel Reeves when ...

Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered a key ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

Chronic stress has been shown to contribute to the development of cancer cells. Here's what doctors recommend to reduce it.

The 11th Cell Biology Industry Conference (CBIC) opened in Beijing, attracting more than 3,000 guests from clinical research ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast cancer with a poorer ...